MedPath

太极集团四川南充制药有限公司

Ownership
-
Established
2008-12-22
Employees
-
Market Cap
-
Website
https://www.taijiny.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

NMPA:42

Drug Approvals

止痛水

Approval Number
国药准字Z51020421
Approval Date
Jun 14, 2024
NMPA

感冒咳嗽颗粒

Approval Number
国药准字Z51020496
Approval Date
Jun 14, 2024
NMPA

板蓝根颗粒

Approval Number
国药准字Z51020153
Approval Date
Jun 14, 2024
NMPA

藿香正气水

Approval Number
国药准字Z51022004
Approval Date
Jun 14, 2024
NMPA

蚕蛾公补合剂

Approval Number
国药准字Z20025875
Approval Date
Jun 14, 2024
NMPA

小柴胡颗粒

Approval Number
国药准字Z20055299
Approval Date
Jun 28, 2020
NMPA

十滴水

Approval Number
国药准字Z20055398
Approval Date
Jun 28, 2020
NMPA

桑杞脑康颗粒

Approval Number
国药准字B20050062
Approval Date
Jun 28, 2020
NMPA

小儿暑感宁糖浆

Approval Number
国药准字Z20055283
Approval Date
Jun 28, 2020
NMPA

十全大补酒

Approval Number
国药准字Z20055397
Approval Date
Jun 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.